Skip to main content
Abbott CEO bullish on Alere purchase completion this year

Abbott Laboratories CEO Miles White said Thursday in an earnings call that he was "quite confident" the company will complete its $5.3 billion acquisition of Alere this year and that Abbott is expected to announce a related asset sale. The company reported that its medical devices business saw an increase of about 89% in sales during the second quarter, generating $2.6 billion on a reported basis.

Full Story: